- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Allergan Inc/United States
Add to PortfolioAGN:US
90.5300 USD 0.0400 0.04%As of 20:04:06 ET on 05/25/2012.
Snapshot for Allergan Inc/United States (AGN)
| Open: | 90.8100 | Day's Range: | 90.1300 - 90.9900 | Volume: | 1,147,345 | Bid: | 90.4900 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 90.4900 | 52wk Range: | 69.4000 - 97.0903 | 1-Yr Rtn: | +9.83% | Ask: | 90.5000 |
Key Statistics for AGN
| Current P/E Ratio (ttm) | 26.4708 |
|---|---|
| Estimated P/E (12/2012) | 21.6838 |
| Earnings Per Share (USD) (ttm) | 3.4200 |
| Est. EPS (USD) (12/2012) | 4.1750 |
| Est. PEG Ratio | 1.5187 |
| Market Cap (M USD) | 27,840.72 |
| Shares Outstanding (M) | 307.53 |
| Enterprise Value (M USD) (ttm) | 26,823.92 |
| Enterprise Value/EBITDA (ttm) | 15.48 |
| Price/Book (mrq) | 5.0522 |
| Price/Sale (ttm) | 4.9716 |
| Dividend Indicated Gross Yield | 0.2210 |
| Next Earnings Announcement | 08/03/2012 |
More AGN Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for AGN
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for AGN
Allergan, Inc. is a multi-specialty health care company that develops and commercializes pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets globally.
| David E I PyottChairman/President/CEO | Herbert W BoyerVice Chairman |
| Douglas S IngramExec VP/President:Emea | Arnold A PinkstonExec VP/General Cnsl/Asst Secy |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page